Joel Greenblatt's SMMT Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 15,727 shares of Summit Therapeutics Inc. (SMMT) worth $298,184, representing 0.00% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 8 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in SMMT for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q3 2024, reducing 3,592 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Summit Therapeutics (SMMT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Summit Therapeutics (SMMT) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | -2 | Reduce 0.01% | 15,727 | $20.66 |
| Q2 2025 | -56 | Reduce 0.35% | 15,729 | $21.28 |
| Q4 2024 | -123 | Reduce 0.77% | 15,785 | $17.84 |
| Q3 2024 | -3,592 | Reduce 18.42% | 15,908 | $21.90 |
| Q2 2024 | +19,500 | New Buy | 19,500 | $7.80 |
Joel Greenblatt's Summit Therapeutics Investment FAQs
Joel Greenblatt first purchased Summit Therapeutics Inc. (SMMT) in Q2 2024, acquiring 19,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Summit Therapeutics Inc. (SMMT) for 8 quarters since Q2 2024.
Joel Greenblatt's largest addition to Summit Therapeutics Inc. (SMMT) was in Q2 2024, adding 19,500 shares worth $152,100.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 15,727 shares of Summit Therapeutics Inc. (SMMT), valued at approximately $298,184.
As of the Q1 2026 filing, Summit Therapeutics Inc. (SMMT) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Summit Therapeutics Inc. (SMMT) was 19,500 shares, as reported at the end of Q2 2024.